Company Overview of Xenerex Biosciences, Inc.
Xenerex Biosciences, Inc. develops an antibody technology. This technology is used to develop human monoclonal antibodies for the treatment of infectious diseases and other therapeutic applications. The company was founded in 2000 and is based in San Diego, California. Xenerex Biosciences, Inc. operates as a subsidiary of Avanir Pharmaceuticals.
11388 Sorrento Valley Road
San Diego, CA 92121
Founded in 2000
Key Executives for Xenerex Biosciences, Inc.
Xenerex Biosciences, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xenerex Biosciences, Inc., please visit www.avanir.com/media/pdf/2007%2008-15%20Xenerex%20Fact%20Sheet.pdf. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.